| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 25 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 25 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 25 |
| 3 | DEXAMETHASONE | 15 |
| 4 | DEXAMETHASONE 1.5 MG | 15 |
| 5 | DARATUMUMAB | 11 |
| 6 | BORTEZOMIB | 10 |
| 7 | METHOTREXATE | 10 |
| 8 | METHOTREXATE SODIUM | 10 |
| 9 | CYTARABINE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MAGNESIUM OXIDE 400MG | 1 | 0.0133 |
| 1 | CIDOFOVIR ANHYDROUS | 3 | 0.0021 |
| 2 | ELOTUZUMAB | 5 | 0.0010 |
| 3 | RISDIPLAM | 2 | 0.0005 |
| 4 | THIOGUANINE | 1 | 0.0005 |
| 5 | FIDAXOMICIN | 1 | 0.0004 |
| 6 | PEGASPARGASE | 5 | 0.0004 |
| 7 | MERCAPTOPURINE | 7 | 0.0004 |
| 8 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 3 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 25 |
| 1 | Corticosteroid [EPC] | 22 |
| 2 | Thalidomide Analog [EPC] | 12 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 11 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| 5 | Proteasome Inhibitor [EPC] | 10 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 9 |
| 7 | Azole Antifungal [EPC] | 7 |
| 8 | Proton Pump Inhibitor [EPC] | 7 |
| 9 | Asparagine-specific Enzyme [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 11 | 0.0019 |
| 1 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 2 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 5 | 0.0010 |
| 3 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 2 | 0.0005 |
| 4 | Asparagine-specific Enzyme [EPC] | 5 | 0.0004 |
| 5 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 6 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 7 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Alkylating Drug [EPC] | 25 | 0.0001 |
| 9 | Sulfone [EPC] | 1 | 0.0001 |